EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Ap...( Lithium Thionyl chloride cells prov...),Health

Lithium Thionyl chloride cells provide high energy density and low entry

cost

JOPLIN, Mo., Jan. 29 /PRNewswire/ -- EaglePicher Technologies, LLC, an EaglePicher company, today announced its Medical Power group introduced two new implantable medical batteries to the market. The two batteries, aimed at the rapidly growing implantable monitor market, provide high energy density and low entry cost. Typical applications include implantable cardiac and glucose monitors.

The two Lithium Thionyl chloride cells, available in 350 mAh and 750mAh formats, join the EaglePicher Medical Power CONTEGO Modular Battery Line. Lithium Thionyl chloride is characterized by a high energy density and low self discharge for maximum reliability.

The cells are fully qualified for implantable applications, manufactured in the United States and available immediately. The CONTEGO series of modular implantable batteries is available in a range of capacities from 500uAh to 3.5Ah.

"Wireless devices are becoming an accepted method for monitoring the body prior to implanting expensive pacing devices or performing cardiac surgery," said Clay Braziller, director of Sales and Marketing, EaglePicher Technologies/Medical Power. "EaglePicher's new Lithium Thionyl chloride cells, with their low cost, low weight and high capacity, are a perfect match for monitoring applications and have already attracted several global customers."

To download a high resolution photo of the new cells, please visit http://www.eaglepicher.com/EaglePicherInternet/Companies/EaglePicher+Medica l+P ower/News/ . (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

EaglePicher Technologies, LLC, an EaglePicher company, is the leading pro
'/>"/>